Journal of Food and Nutrition Research
ISSN (Print): 2333-1119 ISSN (Online): 2333-1240 Website: http://www.sciepub.com/journal/jfnr Editor-in-chief: Prabhat Kumar Mandal
Open Access
Journal Browser
Go
Journal of Food and Nutrition Research. 2018, 6(2), 116-123
DOI: 10.12691/jfnr-6-2-8
Open AccessArticle

Effects of Herbal Mixture Extract on Menopausal Hot Flashes and Pharmacokinetics in Ovariectomized Rat Models

Gyuok Lee1, Jaeyong Kim1, Huwan Kang1, SungYoon Park1, Junkee Hong2, Joohyun Oh2, Jimin Kim2, Chansung Park2, Yongwook Lee2 and Chul-yung Choi1,

1Jeollanamdo Institute of Natural Resources Research, Jangheung-gun, Jeollanamdo, South Korea

2Herbal Hormone Research Institute, Naturalendo Tech Co., Ltd, Gyeonggi, South Korea

Pub. Date: February 28, 2018

Cite this paper:
Gyuok Lee, Jaeyong Kim, Huwan Kang, SungYoon Park, Junkee Hong, Joohyun Oh, Jimin Kim, Chansung Park, Yongwook Lee and Chul-yung Choi. Effects of Herbal Mixture Extract on Menopausal Hot Flashes and Pharmacokinetics in Ovariectomized Rat Models. Journal of Food and Nutrition Research. 2018; 6(2):116-123. doi: 10.12691/jfnr-6-2-8

Abstract

This study was conducted to evaluate the effects of Cynanchum wilfordii Hemsley, Phlomis umbrosa Turcz., and Angelica gigas Nakai extract (CPAE) on the reduction of tail skin temperature (TST) in ovariectomized (OVX) rats. To evaluate TST reduction in ovariectomized rats, 125, 250, and 1000 mg/kg CPAE was administered to rats for 1 week. The measurement of TST after the induction of artificial stress revealed a significant temperature reduction effect in the CPAE administration group (p<0.05). The TST induced by the injection of yohimbine, to induce hot flashes, was found to decrease as the administered dose of CPAE increased from 10 min to 20min (125 and 250 mg/kg/day, p<0.05; 1000 mg/kg/day, p<0.01). In addition, in a drug interaction test between tamoxifen, an anti-estrogen drug, and CPAE, no significant difference was found between the pharmacokinetic (PK) profiles after the administration of tamoxifen only and the combination of tamoxifen and CPAE. We also found that CPAE did not affect CYP2d4 and CYP3a2, which affect tamoxifen metabolism, in a subsequent experiment on liver tissues extracted during the drug interaction test. In this study, we found that CPAE inhibited temperature increase on the tail skin of OVX rats, and therefore is effective in the improvement of hot flashes. CPAE may be potentially used for the improvement of hot flashes induced by the administration of tamoxifen.

Keywords:
Cynanchum wilfordii Cytochrome P450 Hot Flash Tail Skin Temperature Tamoxifen

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

Figures

Figure of 6

References:

[1]  Choi, MS. and Park, JW, “A Study of Educational Need, Attitude and Knowledge toward Menopause in Middle-aged Women,” Korean J Women Health Nurs, 14, 257-269, 2008.
 
[2]  Campagnoli, C., Biglia, N., Peris, C. and Sismondi, P, “Potential Impact on Breast Cancer Risk of Circulating Insulin-Like Growth Factor I Modifications Induced by Oral HRT in Menopause,” Gynecol Endocrinol, 9, 67-74, 1995.
 
[3]  Choi, SY., Oh, HS. and Kang, YS, “The Effects of Health Promotion Program on Stress and Menopausal Symptoms in Menopausal Women,” Korean J Adult Nurs, 19, 353-364, 2007.
 
[4]  Kim J.G. Management of Menopausal Women. 3rd edition (2007).
 
[5]  McKinlay, SM, “The Normal Menopause Transition: An Overview,” Maturitas, 23, 137-145, 1996.
 
[6]  Chun, SW, “The Relationship of Hot Flush to Other Menopausal Symptoms and Chronic Disease Related to Menopause,” J Korean Soc Menopause, 19, 54-63, 2013.
 
[7]  Stearns, V., Ullmer, L. and Lopez JF, “Hot flushes,” Lancet, 360, 1851-1861, 2002.
 
[8]  Song, MH., Hong, KK. and Choi, CM, “Systematic Review of Acupoint Catgut Embedding Therapy for Climacteric Hot Flush,” J Orient Obstet Gynecology, 30, 71-80, 2017.
 
[9]  Rossouw, JE., Anderson, GL., Prentice, RL., LaCroix, AZ., Kooperberg, C., Stefanick, ML., Jackson, RD., Beresford, SA., Howard, BV., Johnson, KC., Kotchen, JM. and Ockene, J, “Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results from the Women's Health Initiative Randomized Controlled Trial,” J Am Med Assoc, 288, 321-333, 2002.
 
[10]  Deirder, RP., Jason, MJ. and Charles, LL, “Management of Menopause-Associated Vasomotor Symptoms: Current Treatment Options, Challenges and Future Directions,” Int J Women Health, 2, 123-135, 2010.
 
[11]  Meier, CR., Jick, SS., Derby, LE., Vasilakis, C. and Jick, H, “Tamoxifen for Early Breast Cancer: an Overview of the Randomised Trials,” Lancet, 351, 1451-1467, 1998.
 
[12]  Fisher, B., Costantino, JP., Wickerham, DL., Redmond, CK., Kavanah, M., Cronin, WM., Vogel, V., Robidoux, A., Dimitrov, N., Daly, JAM., Wieand, S., Tan-Chiu, E., Ford, L. and Wolmark, N, “Tamoxifen for Prevention of Breast Cancer: Report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study,” J Natl Cancer Inst, 90, 1371-1388, 1998.
 
[13]  Shapiro, CL. and Recht, A, “Side effects of adjuvant treatment of breast cancer,” N Engl J Med, 334, 1997-2008, 2001.
 
[14]  Fisher, B., Dignam, J., Wolmark, N., Wickerham, DL., Fisher, ER., Mamounas, E., Smith, R., Begovic, M., Dimitrov, NV., Margolese Richard, G., Kardinal, CG., Kavanah, MT., Fehrenbacher, L. and Oishi, RH, “Tamoxifen in Treatment of Intraductal Breast Cancer: National Surgical Adjuvant Breast and Bowel Project B-24 Randomised Controlled Trial,” Lancet, 353, 1993-2000, 1999.
 
[15]  Loprinzi, CL., Zahasky, KM., Sloan, JA., Nvotny, PJ. and Quella, SK, “Tamoxifen-Induced Hot Flashes,” Clin Breast Cancer, 1, 52-56, 2000.
 
[16]  Love, RR., Cameron, L., Connell, BL. and Levental, H, “Symptoms Associated With Tamoxifen Treatment In Postmenopausal Women,” Arch lntern Med, 151, 1842-1847, 1991.
 
[17]  Catherine, MK., David, NJ., Tara, G., Minh, DH., Kathleen, IP., Peter, CA. and Lawrence, FP. “Selective Serotonin Reuptake Inhibitors and Breast Cancer Mortality in Women Receiving Tamoxifen: a Population based Cohort Study,” BMJ, 340, c693, 2010.
 
[18]  Lee, KH., Lee, DJ., Kim, SM., Je, SH., Kim, EK., Han, HS. and Han, IK, “Evaluation of Effectiveness and Safety of Natural Plants Extract (EstromonⓇ) on Perimenopausal Women for 1 Year.” J Korean Soc Menopause, 11, 16-26, 2005.
 
[19]  Chang, A., Kwak, BY., Yi, KT. and Kim, JS, “The Effect of Herbal Extract (EstroG-100) on Pre-, Peri- and Post-Menopausal Women: a Randomized Double-Blind, Placebo-Controlled Study.” Phytother Res, 26, 510-516, 2012.
 
[20]  Park, MH., Kim and MH, “The Effect of Capsosiphon fulvecense Extract on Inhibition of Platelet Aggregation and Serum Lipid Level in Ovariectomized Rats,” J Life Sci, 15, 1028-1033, 2005.
 
[21]  Karen, MF. and Irving, WW, “Direct Determination of Tamoxifen and its Four Major Metabolites in Plasma Using Coupled Column High-Performance Liquid Chromatography,” J Chromatog B, 655, 261-268, 1994.
 
[22]  Marina, VA., Daniela, DR., Tamyris, SV., Huander, A., Tiago, OF. and Rafael, L, “Sensitive HPLC-PDA Determination of Tamoxifen and its Metabolites N-Desmethyltamoxifen, 4-Hydroxytamoxifen and Endoxifen in Human Plasma,” J Pharm Biomed Anal, 76, 13-20, 2013.
 
[23]  Simpkins, JW., Katovich, MJ. and Song, IC, “Similarities Between Morphine Withdrawal in the Rat and the Menopausal Hot Flash,” Life Sci, 32, 1957-1966, 1983.
 
[24]  Fregly, MJ., Thrasher, TN., MacArthur, SA. and Kelleher, DL, “Attenuation of a Beta-Adrenergic Response in Rats Treated Chronically with Ethynyl Estradiol,” Proc Soc Exp Biol Med, 157, 18-22, 1978.
 
[25]  Owens, NC., Ootsuka, Y., Kanosue, K. and McAllen, RM, “Thermoregulatory Control of Sympathetic Fibres Supplying the Rat’s Tail,” J Physiol, 543, 849-858, 2002.
 
[26]  Tanaka, M., Nagashima, K., McAllen, RM. and Kanosue, K, “Role of the Medullary Raphe in Thermoregulatory Vasomotor Control in Rats,” J Physiol, 540, 657-664, 2002.
 
[27]  Shuto, H., Yamauchi, A., Ikeda, M., Sohda, Y., Koga, A., Tominaga, K., Egawa, T. and Kataoka, Y, “Forced Exercise-Induced Flushing of Tail Skin in Ovariectomized Mice, as a New Experimental Model of Menopausal Hot Flushes,” J Pharmacol Sci, 98, 323-326, 2005.
 
[28]  Freedman, RR, “Biochemical, Metabolic, and Vascular Mechanisms in Menopausal Hot Flashes,” Fertil Steril, 70, 332-337, 1998.
 
[29]  Archer, DF., Sturdee, DW., Baber, R., Villiers, TJ., Pines, A., Freedman, RR., Gompel, A., Hickey, M., Hunter, MS., Lobo, RA., Lumsden, MA., MacLennan, AH., Maki, P., Palacios, S., Shah, D., Villaseca, P. and Warren, M, “Menopausal Hot Flushes and Night Sweats: Where Are We Now?,” Climateric, 14, 515-528, 2011.
 
[30]  Klaus, S., Evelyn, B. and Takahiko, E, “Preferential Blockade of Presynaptic α-Adrenoceptors by Yohimbine,” Eur J Pharmacol, 34, 385-388, 1975.
 
[31]  Robert, RF, “Physiology of Hot Flashes,” Am J Human Biol, 13, 453-464, 2001.
 
[32]  Federicia, LM., Caliman, IF., Molosh, AI. and Fitz, SD., Truitt, WA., Bonaventure, P., Carpenter, JS., Shekhar, A., Johnson, PL, “Hypothalamic Orexin’s Role in Exacerbated Cutaneous Vasodilation Responses to an Anxiogenic Stimulus in a Surgical Menopause Model,” Psychoneuroendocrinology, 65, 127-137, 2016.
 
[33]  Noguchi, M., Ikarashi, Y., Yuzurihara, M., Mizoguchi, K., Kurauchi, K., Chen, JT. and Ishige, A, “Up-Regulation of Calcitonin Gene-Related Peptide Receptors Underlying Elevation of Skin Temperature in Ovariectomized Rats,” J Endocrinol, 175, 177-183, 2002.
 
[34]  Jayasena, CN., Comninos, AN., Stefanopoulou, E., Buckley, A., Narayanaswamy, S., Engbeaya, CI., Abbara, A., Ratnasabapathy, R., Mogford, J., Ng, N., Sarang, Z., Ghatei, MA., Bloom, SR., Hunter, MS. and Dhillo, WS, “Neurokinin B Administration Induces Hot Flushes in Women,” Sci Rep, 5, 8466, 2015.
 
[35]  Lee, GY., Choi, CY. and Jun, WJ, “Effects of Aqueous Extracts of Cynanchum wilfordii in Rat Models for Postmenopausal Hot Flush,” Prev Nutr Food Sci, 21, 373-377, 2016.
 
[36]  Cronin-Fenton, DP., Damkier, p. and Lash, TL, “Metabolism and Transport of Tamoxifen in Relation to its Effectiveness: New Perspectives on an Ongoing Controversy,” Future Oncol, 10, 107-122, 2014.